Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL STOMA/OSTOMY CARE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL STOMA/OSTOMY CARE SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL STOMA/OSTOMY CARE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 EPIDEMIOLOGY
11.1 INCIDENCE OF ALL BY GENDER
11.2 TREATMENT RATE
11.3 MORTALITY RATE
11.4 DRUG ADHERENCE AND THERAPY SWITCH MODEL
11.5 PATIENT TREATMENT SUCCESS RATES
12 EPIDEMIOLOGY
12.1 INCIDENCE OF COLOSTOMATES, ILEOSTOMATES, AND UROSTOMATES
12.2 TREATMENT RATE
12.3 MORTALITY RATE
12.4 DRUG ADHERENCE AND THERAPY SWITCH MODEL
12.5 PATIENT TREATMENT SUCCESS RATES
13 REGULATORY COMPLIANCE
13.1 REGULATORY AUTHORITIES
13.2 REGULATORY CLASSIFICATIONS
13.2.1 CLASS I
13.2.2 CLASS II
13.2.3 CLASS III
13.3 REGULATORY SUBMISSIONS
13.4 INTERNATIONAL HARMONIZATION
13.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
13.6 REGULATORY CHALLENGES AND STRATEGIES
14 REIMBURSEMENT FRAMEWORK
15 OPPUTUNITY MAP ANALYSIS
16 VALUE CHAIN ANALYSIS
17 HEALTHCARE ECONOMY
17.1 HEALTHCARE EXPENDITURE
17.2 CAPITAL EXPENDITURE
17.3 CAPEX TRENDS
17.4 CAPEX ALLOCATION
17.5 FUNDING SOURCES
17.6 INDUSTRY BENCHMARKS
17.7 GDP RATION IN OVERALL GDP
17.8 HEALTHCARE SYSTEM STRUCTURE
17.9 GOVERNMENT POLICIES
17.1 ECONOMIC DEVELOPMENT
18 GLOBAL STOMA/OSTOMY CARE MARKET, BY PRODUCT
18.1 OVERVIEW
18.2 OSTOMY BAGS
18.2.1 BY TYPE
18.2.1.1. COLOSTOMY DRAINAGE BAGS
18.2.1.1.1. ONE-PIECE
18.2.1.1.1.1 CLOSED
18.2.1.1.1.1.1. CUT-TO-FIT
18.2.1.1.1.1.2. PRE-CUT
18.2.1.1.1.1.3. MOLDABLE
18.2.1.1.1.2 OPEN-ENDED/DRAINABLE
18.2.1.1.1.2.1. CUT-TO-FIT
18.2.1.1.1.2.2. PRE-CUT
18.2.1.1.1.2.3. MOLDABLE
18.2.1.1.2. TWO-PIECE
18.2.1.1.2.1 CLOSED
18.2.1.1.2.2 OPEN-ENDED/DRAINABLE
18.2.1.2. UROSTOMY DRAINAGE BAGS
18.2.1.2.1. ONE-PIECE
18.2.1.2.1.1 CLOSED
18.2.1.2.1.1.1. CUT-TO-FIT
18.2.1.2.1.1.2. PRE-CUT
18.2.1.2.1.1.3. MOLDABLE
18.2.1.2.1.2 OPEN-ENDED/DRAINABLE
18.2.1.2.1.2.1. CUT-TO-FIT
18.2.1.2.1.2.2. PRE-CUT
18.2.1.2.1.2.3. MOLDABLE
18.2.1.2.2. TWO-PIECE
18.2.1.2.2.1 CLOSED
18.2.1.2.2.2 OPEN-ENDED/DRAINABLE
18.2.1.3. ILEOSTOMY DRAINAGE BAGS
18.2.1.3.1. ONE-PIECE
18.2.1.3.1.1 CLOSED
18.2.1.3.1.1.1. CUT-TO-FIT
18.2.1.3.1.1.2. PRE-CUT
18.2.1.3.1.1.3. MOLDABLE
18.2.1.3.1.2 OPEN-ENDED/DRAINABLE
18.2.1.3.1.2.1. CUT-TO-FIT
18.2.1.3.1.2.2. PRE-CUT
18.2.1.3.1.2.3. MOLDABLE
18.2.1.3.2. TWO-PIECE
18.2.1.3.2.1 CLOSED
18.2.1.3.2.2 OPEN-ENDED/DRAINABLE
18.2.2 BY SHAPE OF SKIN BARRIER
18.2.2.1. FLAT BASE BAGS
18.2.2.2. CONVEX BAGS
18.3 OSTOMY ACCESSORIES
18.3.1 SKIN BARRIER
18.3.1.1. FLAT BASE BAGS
18.3.1.2. CONVEX BAGS
18.3.1.3. PRE-SIZED SKIN BARRIER
18.3.1.4. CUT-TO-FIT SKIN BARRIER
18.3.1.5. FLEXTEND SKIN BARRIER
18.3.2 PASTES & POWDERS
18.3.3 CREAMS
18.3.4 CLEANSERS
18.3.5 DEODORANTS
18.3.6 TAPES
18.3.7 ADHESIVE REMOVERS
18.3.8 LINERS
18.3.9 OTHERS
19 GLOBAL STOMA/OSTOMY CARE MARKET, BY AGE GROUP
19.1 OVERVIEW
19.2 PEDIATRIC
19.3 GERIATRIC
19.4 ADULT
20 GLOBAL STOMA/OSTOMY CARE MARKET, BY END USER
20.1 OVERVIEW
20.2 HOME CARE SETTINGS
20.2.1 BY PRODUCT
20.2.1.1. OSTOMY BAGS
20.2.1.2. OSTOMY ACCESSORIES
20.3 HOSPITALS
20.3.1 BY TYPE
20.3.1.1. ACUTE CARE HOSPITALS
20.3.1.2. LONG TERM CARE HOSPITALS
20.3.1.3. OTHERS
20.3.2 BY PRODUCT
20.3.2.1. OSTOMY BAGS
20.3.2.2. OSTOMY ACCESSORIES
20.4 SPECIALTY CLINICS
20.4.1 BY PRODUCT
20.4.1.1. OSTOMY BAGS
20.4.1.2. OSTOMY ACCESSORIES
20.5 AMBULATORY SURGICAL CENTERS
20.5.1 BY PRODUCT
20.5.1.1. OSTOMY BAGS
20.5.1.2. OSTOMY ACCESSORIES
20.6 OTHERS
21 GLOBAL STOMA/OSTOMY CARE MARKET, BY DISTRIBUTION CHANNEL
21.1 OVERVIEW
21.2 DIRECT TENDER
21.3 RETAIL SALES
21.3.1 HOSPITAL PHARMACY
21.3.2 RETAIL PHARMACY
21.3.3 ONLINE SALES
21.4 OTHERS
22 GLOBAL STOMA/OSTOMY CARE MARKET, SWOT AND DBMR ANALYSIS
23 GLOBAL STOMA/OSTOMY CARE MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: GLOBAL
23.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
23.3 COMPANY SHARE ANALYSIS: EUROPE
23.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
23.5 MERGERS & ACQUISITIONS
23.6 NEW PRODUCT DEVELOPMENT & APPROVALS
23.7 EXPANSIONS
23.8 REGULATORY CHANGES
23.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24 GLOBAL STOMA/OSTOMY CARE MARKET, BY REGION
GLOBAL STOMA/OSTOMY CARE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
24.1 NORTH AMERICA
24.1.1 U.S.
24.1.2 CANADA
24.1.3 MEXICO
24.2 EUROPE
24.2.1 GERMANY
24.2.2 FRANCE
24.2.3 U.K.
24.2.4 ITALY
24.2.5 SPAIN
24.2.6 RUSSIA
24.2.7 TURKEY
24.2.8 BELGIUM
24.2.9 NETHERLANDS
24.2.10 SWITZERLAND
24.2.11 DENMARK
24.2.12 NORWAY
24.2.13 SWEDEN
24.2.14 FINLAND
24.2.15 POLAND
24.2.16 REST OF EUROPE
24.3 ASIA-PACIFIC
24.3.1 JAPAN
24.3.2 CHINA
24.3.3 SOUTH KOREA
24.3.4 INDIA
24.3.5 AUSTRALIA
24.3.6 SINGAPORE
24.3.7 THAILAND
24.3.8 MALAYSIA
24.3.9 INDONESIA
24.3.10 PHILIPPINES
24.3.11 VIETNAM
24.3.12 NEW ZEALAND
24.3.13 TAIWAN
24.3.14 REST OF ASIA-PACIFIC
24.4 SOUTH AMERICA
24.4.1 BRAZIL
24.4.2 ARGENTINA
24.4.3 REST OF SOUTH AMERICA
24.5 MIDDLE EAST AND AFRICA
24.5.1 SOUTH AFRICA
24.5.2 SAUDI ARABIA
24.5.3 UAE
24.5.4 EGYPT
24.5.5 ISRAEL
24.5.6 OMAN
24.5.7 QATAR
24.5.8 BAHRAIN
24.5.9 REST OF MIDDLE EAST AND AFRICA
24.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
25 GLOBAL STOMA/OSTOMY CARE MARKET, COMPANY PROFILE
25.1 CONVATEC GROUP PLC
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 HOLLISTER INCORPORATED
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 COLOPLAST CORP
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 B. BRAUN SE
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 ALCARE CO., LTD.
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 NU-HOPE LABORATORIES, INC.
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 MARLEN MANUFACTURING & DEVELOPMENT COMPANY
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 WELLAND MEDICAL LIMITED
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 FLEXICARE (GROUP) LIMITED
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.1 CYMED
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 SCHENA OSTOMY TECHNOLOGIES, INC.
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
25.12 SMITH & NEPHEW
25.12.1 COMPANY OVERVIEW
25.12.2 REVENUE ANALYSIS
25.12.3 GEOGRAPHIC PRESENCE
25.12.4 PRODUCT PORTFOLIO
25.12.5 RECENT DEVELOPMENTS
25.13 SALTS HEALTHCARE.
25.13.1 COMPANY OVERVIEW
25.13.2 REVENUE ANALYSIS
25.13.3 GEOGRAPHIC PRESENCE
25.13.4 PRODUCT PORTFOLIO
25.13.5 RECENT DEVELOPMENTS
25.14 3M COMPANY
25.14.1 COMPANY OVERVIEW
25.14.2 REVENUE ANALYSIS
25.14.3 GEOGRAPHIC PRESENCE
25.14.4 PRODUCT PORTFOLIO
25.14.5 RECENT DEVELOPMENTS
25.15 MEDEREN NEOTECH LTD.
25.15.1 COMPANY OVERVIEW
25.15.2 REVENUE ANALYSIS
25.15.3 GEOGRAPHIC PRESENCE
25.15.4 PRODUCT PORTFOLIO
25.15.5 RECENT DEVELOPMENTS
25.16 PROWESS CARE
25.16.1 COMPANY OVERVIEW
25.16.2 REVENUE ANALYSIS
25.16.3 GEOGRAPHIC PRESENCE
25.16.4 PRODUCT PORTFOLIO
25.16.5 RECENT DEVELOPMENTS
25.17 LOHMANN GMBH & CO. KG
25.17.1 COMPANY OVERVIEW
25.17.2 REVENUE ANALYSIS
25.17.3 GEOGRAPHIC PRESENCE
25.17.4 PRODUCT PORTFOLIO
25.17.5 RECENT DEVELOPMENTS
25.18 POREX
25.18.1 COMPANY OVERVIEW
25.18.2 REVENUE ANALYSIS
25.18.3 GEOGRAPHIC PRESENCE
25.18.4 PRODUCT PORTFOLIO
25.18.5 RECENT DEVELOPMENTS
25.19 SARASOTA MEDICAL PRODUCTS
25.19.1 COMPANY OVERVIEW
25.19.2 REVENUE ANALYSIS
25.19.3 GEOGRAPHIC PRESENCE
25.19.4 PRODUCT PORTFOLIO
25.19.5 RECENT DEVELOPMENTS
25.2 NARANG MEDICAL LIMITED.
25.20.1 COMPANY OVERVIEW
25.20.2 REVENUE ANALYSIS
25.20.3 GEOGRAPHIC PRESENCE
25.20.4 PRODUCT PORTFOLIO
25.20.5 RECENT DEVELOPMENTS
25.21 ZHEJIANG AILEBAO MEDICAL TECHNOLOGY CO.,LTD
25.21.1 COMPANY OVERVIEW
25.21.2 REVENUE ANALYSIS
25.21.3 GEOGRAPHIC PRESENCE
25.21.4 PRODUCT PORTFOLIO
25.21.5 RECENT DEVELOPMENTS
25.22 HARRO HÖFLIGER
25.22.1 COMPANY OVERVIEW
25.22.2 REVENUE ANALYSIS
25.22.3 GEOGRAPHIC PRESENCE
25.22.4 PRODUCT PORTFOLIO
25.22.5 RECENT DEVELOPMENTS
26 RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
